Bleeding after menopause while using HRT: what to report

Tell the clinician what happened

Note when the bleeding began, whether it is spotting or a heavier flow, whether it has happened before and whether there is pain. Include pink or brown discharge and bleeding after sex; you do not have to decide the cause before reporting it.

The NHS advises assessment of postmenopausal bleeding even without other symptoms. Many causes are not cancer, but evaluation matters because cancer is one possible cause. A review article or symptom checker cannot determine which explanation applies to you.

Explain your exact HRT schedule

Different HRT regimens can have different expected bleeding patterns. Sequential combined HRT may include a scheduled withdrawal bleed, while continuous combined treatment follows a different pattern. Starting or changing treatment may also affect bleeding.

Tell the clinician the names and routes of every hormone medicine, when you started each, any recent change and any missed doses. Do not infer that a bleed is expected just because you have heard that HRT can cause spotting. Ask the prescriber what is expected with your specific regimen and which changes require assessment.

Uterine protection is part of the history

For someone with a uterus using systemic estrogen, the progestogen component usually has an important role in protecting the uterine lining. Let the clinician know if you have stopped it, had difficulty taking it or are uncertain about the instructions.

Our progesterone guide explains that role without setting a personal treatment schedule. If you have had surgery, bring the details; HRT after hysterectomy explains why knowing what was removed matters. Do not restart, stop or change a medicine based solely on this article.

An online conversation may be only the first step

The clinician may recommend a local examination, ultrasound or another investigation depending on your history. The NHS describes several possible tests for postmenopausal bleeding, but not everyone needs the same tests and US referral arrangements differ.

Ask who will arrange the next step and how you will receive the result. A telehealth provider should be clear about what it can evaluate remotely and what needs another setting. If the service cannot assess your concern, ask for an appropriate local route rather than continuing to shop for a prescription online.

Keep the message short and specific

You could write: “I use these HRT medicines, started them on this date, and have had unexpected bleeding since this date. Please tell me how soon I need assessment and whether I need an in-person appointment.” Add the amount of bleeding, associated symptoms and relevant medical history.

Use the clinic’s medical contact channel, and ask what to do if a response does not arrive within its stated timeframe. The follow-up guide helps with routine reviews, but a new bleeding concern should not be held until a distant annual appointment simply because that review is already scheduled. A clear report and an explicit assessment plan are the next useful steps.